Trial
NCT05411107
Oral Iloprost for the Prevention of Lung Cancer In Former Smokers
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
National Cancer Institute (NCI)
Collaborators
—
Condition
Bronchial Epithelial Dysplasia
Intervention
Biospecimen Collection
Why stopped
Agent is not available
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-05-17